human
coronaviru
respiratori
viru
usual
caus
common
cold
howev
potenti
caus
sever
infect
young
children
immunocompromis
adult
sarscov
merscov
shown
express
protein
potenti
evad
earli
innat
immun
respons
howev
abil
antagonis
intracellular
antivir
defenc
yet
investig
potenti
role
structur
n
accessori
protein
alter
antivir
gene
express
investig
studi
n
protein
express
human
embryon
kidney
cell
challeng
sendai
viru
human
antivir
respons
pcr
array
use
profil
antivir
gene
express
cell
gene
downregul
presenc
one
protein
eg
gene
repres
mitogenactiv
protein
kinas
tolllik
receptor
interferon
interleukin
signal
transduct
protein
find
suggest
similarli
sarscov
merscov
abil
downregul
transcript
gene
critic
activ
differ
antivir
signal
pathway
studi
need
confirm
role
structur
accessori
protein
antagonis
antivir
gene
express
human
coronaviru
taxonom
classifi
within
coronavirida
famili
also
includ
sever
acut
respiratori
syndrom
sar
middl
east
respiratori
syndrom
mer
coronavirus
belong
subgroup
betacoronavirus
positivesens
singlestrand
rna
virus
larg
genom
size
base
viral
protein
contribut
structur
coronavirus
includ
membran
nucleocapsid
n
envelop
e
spike
glycoprotein
betacoronavirus
possess
uniqu
protein
surfac
alongsid
glycoprotein
call
hemagglutinin
esteras
coronaviru
possess
set
uniqu
accessori
protein
accessori
protein
call
common
circul
coronavirus
caus
common
cold
upper
lower
respiratori
tract
infect
subclin
mild
infect
common
occur
throughout
year
howev
human
coronavirus
sarscov
merscov
respons
hospitalis
young
children
immunocompromis
adult
respiratori
tract
ill
seem
also
potenti
neurotrop
neuroinvas
associ
multipl
sclerosi
moreov
detect
cerebrospin
fluid
child
acut
dissemin
encephalomyel
case
fatal
enceph
associ
infect
recent
report
immunodefici
boy
sever
studi
human
coronaviru
interact
host
cell
innat
immun
respons
conduct
sarscov
merscov
high
casefat
rate
associ
infect
vero
cell
express
sarscov
n
protein
interleukin
activ
nuclear
factor
kappa
b
contrari
protein
sarscov
suppress
activ
contribut
pathogenesi
viru
addit
mani
protein
sarscov
shown
abil
antagonis
interferon
ifn
counteract
innat
immun
respons
accessori
protein
potenti
antagonis
ifn
differ
mechan
sarscov
protein
recent
shown
suppress
ifn
product
structur
accessori
protein
merscov
shown
potent
ifn
antagonist
still
unknown
whether
evas
mechan
describ
certain
role
sever
sar
mer
noteworthi
sever
peopl
infect
sarscov
merscov
develop
sever
symptom
research
sar
mer
done
one
specif
viru
activ
inhibit
innat
immun
respons
none
studi
conduct
far
compar
result
associ
low
mortal
rate
may
abil
sarscov
merscov
evad
innat
immun
inde
studi
investig
interact
host
cell
innat
immun
respons
n
protein
shown
caus
prolong
activ
nexpress
cell
furthermor
infect
cell
line
deriv
human
respiratori
tract
epithelia
hepatocyt
enhanc
three
type
ifn
due
interact
ifninduc
transmembran
ifitm
protein
moreov
acetylesteras
activ
protein
strongli
enhanc
product
infecti
viru
sarscov
merscov
receiv
much
attent
scientif
commun
littl
research
address
effect
human
coronaviru
infect
antivir
gene
express
potenti
role
structur
accessori
protein
alter
antivir
gene
express
cell
investig
studi
human
embryon
kidney
cell
obtain
american
type
cultur
collect
atcc
manassa
va
usa
grown
dulbecco
minim
essenti
medium
dmem
contain
life
technolog
corpor
tm
grand
island
ny
usa
use
cm
tissu
cultur
flask
medium
supplement
fetal
bovin
serum
fb
life
technolog
tm
life
technolog
tm
penicillin
g
uml
life
technolog
streptomycin
sulfat
pgml
life
technolog
tm
monolay
cell
cultur
flask
incub
presenc
carbon
dioxid
co
humid
human
coronaviru
influenza
viru
ahong
strain
sendai
viru
obtain
atcc
amplif
n
gene
rtpcr
rna
extract
use
viral
rna
minikit
qiagen
tm
gmbh
hilden
germani
accord
manufactur
instruct
n
gene
amplifi
twostep
revers
transcriptionpolymeras
chain
reaction
rtpcr
use
rna
core
kit
appli
biosystem
tm
foster
citi
ca
usa
pmol
previous
describ
primer
pcr
system
appli
biosystem
tm
rt
reaction
condit
anneal
minut
denatur
minut
cool
thereaft
cdna
amplifi
pcr
use
follow
condit
denatur
minut
cycl
denatur
second
anneal
second
extens
second
follow
final
extens
step
minut
cool
pcr
product
run
agaros
gel
band
sizespecif
amplifi
gene
interest
cut
purifi
sv
gel
pcr
clean
system
promega
tm
madison
wi
usa
accord
manufactur
instruct
influenza
viru
rna
also
isol
use
amplifi
gene
rtpcr
use
primer
influenza
protein
use
posit
control
ifn
antagon
readi
vector
clontech
tm
takara
bio
compani
mountain
view
ca
usa
use
clone
rtpcr
product
hd
clone
kit
clontech
tm
use
set
ligat
reaction
compet
e
coli
cell
invitrogen
tm
carlsbad
ca
usa
use
transform
isol
vector
achiev
use
plasmid
miniprep
kit
promega
accord
manufactur
instruct
confirm
success
clone
achiev
use
restrict
digest
direct
sequenc
cell
seed
x
per
well
plate
transfect
use
accord
manufactur
instruct
express
n
protein
confirm
indirect
immunofluoresc
assay
ifa
use
antigfp
monoclon
antibodi
clone
clontech
tm
express
n
protein
confirm
ifa
use
monoclon
antibodi
emd
millipor
tm
billerica
usa
polyclon
antibodi
influenza
protein
emd
millipor
tm
respect
transfect
mocktransfect
cell
grown
confluenc
plate
presenc
co
media
remov
sendai
viru
suspens
atcc
ad
well
multipl
infect
moi
plate
incub
co
humid
human
antivir
respons
pcr
array
qiagen
tm
use
profil
antivir
gene
express
cell
two
separ
experi
pcr
array
monitor
transcript
activ
differ
gene
involv
activ
antivir
proinflammatori
protein
follow
amplif
rna
transcript
realtim
rtpcr
total
rna
transfect
mocktransfect
cell
extract
use
kit
qiagen
tm
oncolumn
dnase
digest
accord
manufactur
instruct
rt
first
strand
kit
qiagen
tm
use
cdna
synthesi
rt
reaction
ad
rt
sybr
green
rox
qpcr
mastermix
qiagen
tm
pcr
carri
plate
qiagen
tm
abi
fast
realtim
pcr
system
appli
biosystem
tm
cycl
threshold
c
valu
export
excel
file
creat
tabl
c
valu
tabl
upload
qiagen
data
analysi
web
portal
http
wwwqiag
ncomgeneg
lobe
qualiti
control
perform
array
contain
control
monitor
genom
dna
contamin
gdc
first
strand
synthesi
rtc
realtim
pcr
effici
ppc
sampl
assign
control
test
group
c
valu
normalis
base
manual
select
refer
gene
glyceraldehyd
dehydrogenas
gapdh
chosen
housekeep
refer
gene
fold
regul
comparison
use
profil
antivir
gene
express
fold
changeregul
calcul
use
delta
delta
c
method
calcul
gene
interest
goi
gapdh
follow
calcul
test
group
control
group
fold
chang
calcul
use
formula
thereaft
data
analysi
web
portal
use
provid
scatter
plot
volcano
plot
clustergram
heat
map
fold
regul
threshold
upregul
downregul
fold
chang
gene
express
differ
experi
summaris
mean
standard
deviat
differ
mean
fold
chang
two
group
determin
independentsampl
ttest
pvalu
consid
signific
statist
analys
perform
use
ibm
spss
statist
softwar
version
window
ibm
corpor
armonk
ny
usa
protein
compar
mockand
nontransfect
cell
express
oncogen
fo
upregul
across
sampl
tabl
nevertheless
gene
downregul
presenc
one
protein
eg
mitogenactiv
protein
kinas
tolllik
receptor
caspas
cathepsin
ctss
interferon
interleukin
signal
transduct
protein
mav
tabl
similar
result
obtain
presenc
influenza
protein
wellknown
ifn
antagonist
tabl
mean
neg
fold
chang
presenc
structur
protein
n
larger
presenc
accessori
protein
p
contrast
express
gene
downregul
presenc
protein
presenc
n
protein
p
downregul
ctss
gene
express
greater
presenc
n
protein
presenc
protein
p
gene
express
downregul
presenc
protein
presenc
n
protein
p
contrari
downregul
presenc
protein
presenc
n
protein
p
sendai
viru
wellknown
induc
antivir
gene
use
challeng
cell
total
gene
upregul
presenc
sendai
viru
wherea
gene
downregul
tabl
strong
posit
fold
chang
fo
jun
cell
presenc
n
protein
challeng
cell
sendai
viru
result
upregul
gene
downregul
gene
tabl
express
upregul
presenc
protein
influenza
protein
posit
fold
chang
observ
three
chemokin
two
rigilik
receptor
one
interferon
one
ubiquitinlik
protein
wherea
drastic
downregul
express
neg
fold
chang
rang
fo
ctss
mefv
pycard
fadd
mav
cyld
tnf
tabl
fo
jun
also
show
substanti
neg
fold
chang
tabl
express
gene
downregul
presenc
protein
presenc
protein
p
wherea
express
gene
downregul
presenc
protein
presenc
protein
p
moreov
express
jun
gene
downregul
presenc
n
protein
p
interestingli
express
gene
downregul
presenc
n
protein
presenc
influenza
protein
express
downregul
presenc
protein
presenc
influenza
protein
express
pycard
downregul
presenc
one
test
protein
presenc
influenza
protein
moreov
fo
gene
express
downregul
presenc
n
protein
presenc
influenza
protein
tabl
current
studi
show
first
time
differ
gene
involv
activ
antivir
inflammatori
respons
eg
repres
interleukin
ifn
mapk
prr
adaptor
protein
downregul
presenc
structur
accessori
protein
similar
antivir
gene
express
profil
observ
influenza
protein
known
antagonis
type
ifn
activ
protein
interestingli
gene
downregul
presenc
protein
presenc
influenza
protein
accessori
protein
often
essenti
viru
replic
vitro
requir
optim
replic
virul
natur
host
accessori
protein
known
viroporin
involv
virion
morphogenesi
pathogenesi
absenc
reduct
virul
inflamm
replic
infect
mice
murin
coronaviru
accessori
protein
homolog
protein
found
antagonis
ifn
induct
result
show
express
prr
mav
import
induct
antivir
respons
downregul
presenc
accessori
protein
moreov
express
interleukin
chemokin
fo
jun
irf
downregul
presenc
protein
fo
jun
transcript
factor
involv
induct
inflammatori
cytokin
altogeth
result
suggest
potenti
induc
shift
toward
antiinflammatori
respons
blockag
type
ifn
pathway
howev
vivo
studi
requir
confirm
type
immun
respons
elicit
infect
absenc
adequ
immun
respons
viru
abl
replic
spread
freeli
protein
indispens
virion
assembl
golgi
apparatu
endoplasm
reticulum
abund
protein
among
coronaviru
protein
sarscov
protein
suppress
activ
also
halt
ifn
product
block
format
complex
merscov
protein
also
potent
ifn
antagonist
target
interact
inhibit
phosphoryl
moreov
tradd
fadd
key
player
apoptosi
pathway
result
show
express
downregul
presenc
test
protein
downregul
could
confirm
stimul
sendai
studi
need
confirm
effect
protein
type
ifn
signal
pathway
function
n
protein
ensur
replic
transcript
viral
rna
disrupt
cell
cycl
inde
sarscov
n
protein
inhibit
progress
cell
cycl
activ
proinflammatori
factor
moreov
shown
sarscov
n
protein
inhibit
express
activ
express
protein
potenti
bind
inhibitor
microrna
studi
show
signific
fold
chang
express
presenc
n
protein
howev
signific
downregul
express
prr
adaptor
protein
mav
signal
mediat
ikbkb
tradd
traf
critic
induct
signal
pathway
moreov
result
show
express
mapk
downregul
presenc
n
protein
line
previou
studi
show
murin
coronaviru
n
protein
inhibit
signal
complex
compos
fo
jun
oncogen
whose
express
also
downregul
investig
presenc
n
protein
challeng
sendai
viru
also
call
transform
growth
factorb
tgfb
activ
kinas
downregul
fo
jun
pycard
ikbkb
fadd
tradd
mav
ctsb
gene
presenc
protein
test
challeng
cell
sendai
viru
protein
kinas
known
critic
mediat
inflammatori
respons
activ
lipopolysaccharid
lp
tlrnlr
agonist
bind
lp
receptor
activ
common
pathway
wherebi
kinas
recruit
activ
via
similar
mechan
mediat
activ
lead
gener
polyubiquitin
chain
bind
adaptor
protein
bound
constitut
accessori
protein
homolog
activ
transduc
signal
cjun
ntermin
kinas
jnk
via
phosphoryl
ikk
mitogenactiv
protein
kinas
kinas
respect
ultim
transcript
factor
downstream
jnk
activ
result
transcript
gene
import
inflammatori
immun
respons
interestingli
protein
kinas
r
pkr
interact
scaffold
protein
mediat
mapk
activ
strong
downregul
express
observ
studi
could
due
inhibit
express
direct
interact
protein
prevent
bind
mediat
like
upregul
express
neg
regul
like
phosphatas
deubiquitinas
ubiquitinspecif
peptidas
certain
cell
line
ifitm
protein
shown
facilit
entri
host
cell
studi
show
test
protein
abl
downregul
express
suggest
resist
induct
interact
protein
host
cell
requir
investig
understand
process
could
contribut
overal
resist
antivir
state
protein
potenti
inhibitori
effect
express
close
proxim
infect
cell
indic
high
replic
capac
viru
conclus
find
suggest
similarli
sarscov
merscov
abil
downregul
transcript
gene
critic
activ
differ
antivir
signal
pathway
sarscov
merscov
shown
induc
proinflammatori
cytokin
vitro
accessori
structur
protein
potenti
inhibit
inflammatori
respons
cell
studi
progress
confirm
role
structur
accessori
protein
antagonis
antivir
gene
express
elucid
natur
immun
respons
level
inflamm
seen
infect
fund
work
support
kuwait
univers
research
administr
grant
ym
